Anixa Biosciences To Presentation Its Ovarian Cancer CAR-T Clinical Trial At The IGCS 2024 Annual Meeting October 16-18, 2024
Portfolio Pulse from Benzinga Newsdesk
Anixa Biosciences, Inc. (NASDAQ:ANIX) will present its ovarian cancer CAR-T therapy clinical trial at the IGCS 2024 Annual Meeting in Dublin, Ireland, from October 16-18, 2024. The presentation will be led by Dr. Robert Wenham from Moffitt Cancer Center.

July 29, 2024 | 12:48 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Anixa Biosciences will present its ovarian cancer CAR-T therapy clinical trial at the IGCS 2024 Annual Meeting. This could generate positive attention and potential investor interest in the company's innovative cancer treatment.
The presentation at a prestigious conference like IGCS can increase visibility and credibility for Anixa's CAR-T therapy, potentially attracting investor interest and positively impacting the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100